Product Information
POTASSIUM CL ER 8 MEQ CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.1025 per EA under NDC 62037055905. Its NADAC has been published 658 times since Nov 28, 2013.
FDA first approved this application on Jun 2, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
62037055905
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077419FDA Approved
6/2/2008
TE Code
AB
On Market Since
8/25/2008
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has been published 658 times since Nov 28, 2013, and over the history we have for it it has declined 82.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1025 per EA |
|---|---|
| All-time high | $0.6513 (Aug 10, 2016) |
| All-time low | $0.1025 (Jun 17, 2026) |
| 52-week high | $0.1336 |
| 52-week low | $0.1025 |
| Median price | $0.2866 |
| Average price | $0.3157 |
| Largest weekly change | +73.8% (Apr 18, 2018) |
| Weeks tracked | 658 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
-11.7%
1Y
-23.3%
3Y
-39.9%
5Y
-43.1%
All
-82.9%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 8 MEQ CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ CAPSULE, manufactured by Actavis Pharma, Inc., is $0.1025 per EA (NDC 62037055905), effective Jul 1, 2026.
How has the price of POTASSIUM CL ER 8 MEQ CAPSULE changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has declined 82.9%. It has been tracked across 658 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ CAPSULE?
Since Nov 28, 2013, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has ranged from a low of $0.1025 (Jun 17, 2026) to a high of $0.6513 (Aug 10, 2016), with a median of $0.2866 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 8 MEQ CAPSULE, is $0.0998 per EA — about 3% below POTASSIUM CL ER 8 MEQ CAPSULE.
Who manufactures POTASSIUM CL ER 8 MEQ CAPSULE?
POTASSIUM CL ER 8 MEQ CAPSULE (NDC 62037055905) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.